Victims of U.K.’s infected blood scandal to start receiving final compensation payments this year
LONDON — Victims of the U.K.’s infected blood scandal, in which tens of thousands of people were infected by contaminated blood or blood products provided by the public health service, will start receiving their final compensation payments this year, the government said Tuesday.
Officials announced the compensation plans a day after the publication of a report that found civil servants and doctors exposed patients to unacceptable risks by giving them blood transfusions or blood products tainted with HIV or hepatitis from the 1970s to the early 1990s.
The scandal is seen as the deadliest disaster in the history of Britain’s state-run National Health Service since its inception in 1948. Prime Minister Rishi Sunak on Monday apologized for the “decades-long moral failure at the heart of our national life.â€
The report said successive U.K. governments refused to admit wrongdoing and tried to cover up the scandal, in which an estimated 3,000 people died after receiving the contaminated blood or blood products. In total, the report said about 30,000 people were infected with HIV or hepatitis C, a kind of liver infection, over the period.
Some 3,000 people died and many others had lifelong illnesses after receiving blood tainted with HIV or hepatitis in Britain from the 1970s to the early 1990s.
Cabinet Office Minister John Glen told lawmakers on Tuesday that he recognized that “time is of the essence,†and that victims who need payments most urgently will receive a further interim compensation of £210,000 ($267,000) within 90 days, ahead of the establishment of the full payment plan.
He also said that friends and family who have cared for those infected would also be eligible to claim compensation.
Authorities made a first interim payment of £100,000 in 2022 to each survivor and bereaved partner. Glen did not confirm the total cost of the compensation package, though it is reported to be more than £10 billion ($12.7 billion).
But Des Collins, a lawyer representing dozens of the victims, said many bereaved families have not received any payments to date and have no information on how to claim interim payments pledged to the estates of those who have died.
Campaigners have fought for decades to bring official failings to light and secure government compensation. The inquiry was finally approved in 2017, and over the past four years it reviewed evidence from more than 5,000 witnesses and over 100,000 documents.
Many of those affected were people with hemophilia, a condition affecting the blood’s ability to clot. In the 1970s, patients were given a new treatment from the United States that contained plasma from high-risk donors, including prison inmates, who were paid to give blood.
The quivering voice was that of a middle-aged woman turning to a radio talk show for advice.
Because manufacturers of the treatment mixed plasma from thousands of donations, one infected donor would compromise the whole batch.
The report said around 1,250 people with bleeding disorders, including 380 children, were infected with HIV-tainted blood products. Three-quarters of them have died. Up to 5,000 others who received the blood products developed chronic hepatitis C.
An estimated 26,800 others were also infected with hepatitis C after receiving blood transfusions, often given in hospitals after childbirth, surgery or an accident, the report said.
The disaster could have largely been avoided had officials taken steps to address the known risks linked to blood transfusions or the use of blood products, the report concluded, adding that the U.K. lagged behind many developed countries in introducing rigorous screening of blood products and blood donor selection.
The harm done was worsened by concealment and a defensive culture within the government and health services, the inquiry added.
Hui writes for the Associated Press.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
